Abstract: The present invention provides a solution mixture of 1.8 to 3.7% hypertonic saline, 70 to 85% ethanol as solvent alternating with 10 milliliters 50 to 90% of 75 to 110 mg theobromine in a nebulized aerosol for inhalation by COVID-19 and SARS patients. Alternatively, theobromine may be infused alternating with inhaled nebulized exogenous pulmonary surfactant as replacement. For advanced COVID-19, SARS patients, the inhalation described above may be alternated with an intravenous solution of 1.8% to 2.2% hypertonic solution of theobromine as 450 mg to 650 mg in ethanol, twice daily.

Abstract: The present invention provides a solution mixture of 1.8 to 3.7% hypertonic saline, 70 to 85% ethanol as solvent alternating with 10 milliliters 50 to 90% of 75 to 110 mg theobromine in a nebulized aerosol for inhalation by COVID-19 and SARS patients. Alternatively, theobromine may be infused alternating with inhaled nebulized exogenous pulmonary surfactant as replacement. For advanced COVID-19, SARS patients, the inhalation described above may be alternated with an intravenous solution of 1.8% to 2.2% hypertonic solution of theobromine as 450 mg to 650 mg in ethanol, twice daily.

Abstract: A portable rescue inhaler having a first canister containing a gas mixture of helium, oxygen, and nitrogen, and having a second canister containing an aerosolized medicine. The gas mixture of helium, oxygen, and nitrogen contained in the first canister has a density slightly lower than the density of atmospheric air. The portable rescue inhaler is capable of delivering the lower density gas mixture simultaneously with the aerosolized medicine for emergency hand held rescue of patients suffering from asthma, asthmatic bronchitis, COPD, emphysema, cystic fibrosis, and myocardial insufficiency. The portable rescue inhaler is capable of providing a vaporized anesthetic for greater medical assistance for patients in need of anesthesia due to respiratory insufficiency. The portable rescue inhaler reduces intra-operative risks in respiratory patients prior to gaining access to a hospital or care center.

Abstract: A portable rescue inhaler having a first canister containing a gas mixture of helium, oxygen, and nitrogen, and having a second canister containing an aerosolized medicine. The gas mixture of helium, oxygen, and nitrogen contained in the first canister has a density slightly lower than the density of atmospheric air. The portable rescue inhaler is capable of delivering the lower density gas mixture simultaneously with the aerosolized medicine for emergency hand held rescue of patients suffering from asthma, asthmatic bronchitis, COPD, emphysema, cystic fibrosis, and myocardial insufficiency. The portable rescue inhaler is capable of providing a vaporized anesthetic for greater medical assistance for patients in need of anesthesia due to respiratory insufficiency. The portable rescue inhaler reduces intra-operative risks in respiratory patients prior to gaining access to a hospital or care center.

Abstract: An inhalation device which entrains air to modify a source gas, such as pure oxygen, down to different selected levels of lower gas concentrations, with a high total gas flow being achieved for inhalation. The inhalation device allows eating and suctioning without interference while maintaining a constant uninterrupted gas supply at high volumes. The inhalation device is adapted for disposal adjacent to the nose and mouth of a person, and includes a nose hood connected to a chamber. The chamber has a central portion defining a longitudinal axis orientated perpendicular to the nose hood and also defining an opening aligned with and facing the nose in a configuration such that gas is inhalable from the central portion to the nose without the gas directly impacting the breathing orifices of a patient wearing the device.

Abstract: An inhalation device utilizing a controlled oxygen concentration selected which entrains air to modify a source gas, such as pure oxygen at 100% down to different selected levels of lower oxygen concentrations with a high total gas flow being achieved for inhalation without being perpendicular to the breathing orifices and allowing eating and suctioning without interference thus maintaining a constant uninterrupted oxygenation supply during eating and or suctioning is provided, which is adapted for disposal adjacent a nose and a mouth of a subject, including a nose hood connected to a chamber. The chamber has a central portion defining a longitudinal axis oriented perpendicular to the nose hood. A mixing section delivers fluid to a first end portion of the chamber in a fluid flow path configured to travel in a direction along the longitudinal axis and exit from a second end portion, coaxial with the first end portion.

Abstract: A filter material for generating oxygen and/or hydrogen gas from a source having a porous boron doped carbon film with diRuthenium/diRuthenium molecules in direct contact with the porous boron doped carbon film, a synthetic film having at least one zeolite crystalline body in direct contact with the nanocarbon tubules, or both in a continuous alternating arrangement.

Abstract: A filter material for generating oxygen and/or hydrogen gas from a source having a porous boron doped carbon film with diruthenium/diruthenium molecules in direct contact with the porous boron doped carbon film, a synthetic film having at least one zeolite crystalline body in direct contact with the nanocarbon tubules, or both in a continuous alternating arrangement.

Abstract: Ruthenium containing compounds and compositions which inhibit the cellular mitochondrial electron transfer mechanism by providing electrochemically-generated oxygen to an oxygen-deprived environment. Also provided are pharmaceutical compositions containing the same and methods for treating cancer using the pharmaceutical compositions.

Abstract: A filter material for generating oxygen and/or hydrogen gas from a source having a porous boron doped carbon film with diRuthenium/diRuthenium molecules in direct contact with the porous boron doped carbon film, a synthetic film having at least one zeolite crystalline body in direct contact with the nanocarbon tubules, or both in a continuous alternating arrangement.

Abstract: A filter material for generating oxygen and/or hydrogen gas from water having a porous boron doped carbon film with diRuthenium/diRuthenium molecules and at least one fluorine ion in direct contact with the porous boron doped carbon film which further comprising a synthetic film made from a nanocarbon tubular mesh network attached with zeolite crystalline and a siderophore plate for capturing dislodged free Ruthenium ion from the porous boron doped carbon film.

Abstract: An apparatus for providing oxygen and/or hydrogen by splitting water and filtering out oxygen from exhaled air, atmospheric air, and/or air from a fan motor using an alternating repeating catalytic and filtering screens with the first screen in the repeating unit having diRuthenium and second screen having Zeolite crystalline bodies.

Abstract: An apparatus for producing oxygen in an atmosphere substantially devoid of breathable oxygen.

Abstract: A filter material for generating oxygen and/or hydrogen gas from a source having a porous boron doped carbon film with diRuthenium/diRuthenium molecules in direct contact with the porous boron doped carbon film, a synthetic film having at least one zeolite crystalline body in direct contact with the nanocarbon tubules, or both in a continuous alternating arrangement.